These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11719430)

  • 1. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
    Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
    Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
    Boone B; Haspeslagh M; Brochez L
    J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
    Rodeck U; Nishiyama T; Mauviel A
    Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKI pathways inducing progression of human melanoma.
    Reed JA; Lin Q; Chen D; Mian IS; Medrano EE
    Cancer Metastasis Rev; 2005 Jun; 24(2):265-72. PubMed ID: 15986136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis.
    Medrano EE
    Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and malignant melanoma: molecular mechanisms.
    Hussein MR
    J Cutan Pathol; 2005 Jul; 32(6):389-95. PubMed ID: 15953371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
    Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
    Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
    Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.